Synapse - Andrew Zelenetz

Search Within

Andrew D Zelenetz

Results (127)

The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma

Journal Article

Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
Bone Marrow Transplantation (2009)

Fulltext@MSK | Save

Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma

Journal Article

Gerecitano, J.; Portlock, C.; Moskowitz, C.; Hamlin, P.; Straus, D.; Zelenetz, A. D.; Zhang, Z.; Dumitrescu, O.; Sarasohn, D.; Lin, D.; more...
British Journal of Haematology (2009)

Fulltext@MSK | Save

Influence of post-second-line chemotherapy PET Imaging and involved field radiotherapy prior to high dose therapy on outcomes of relapsed or refractory diffuse large B cell lymphoma

Meeting Abstract

Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Kewalramani, T.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
International Journal of Radiation Oncology, Biology, Physics (2008)

Fulltext@MSK | Save

Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity

Journal Article

Hoppe, B. S.; Moskowitz, C. H.; Filippa, D. A.; Moskowitz, C. S.; Kewalramani, T.; Zelenetz, A. D.; Yahalom, J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Feasiblity and implication of bidirectional sequencing using a multiplex framework 2 region primer for somatic mutation analysis of the immunoglobulin (IgH) heavy chain in chronic lymphocytic leukemia (CLL)

Meeting Abstract

Nelson, A.; Rijo, I.; Zhang, Z. G.; Zelenetz, A. D.; Noy, A.
Blood (2007)

Fulltext@MSK | Save

Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience

Meeting Abstract

O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
Blood (2006)

Fulltext@MSK | Save

Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia

Journal Article

Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas

Journal Article

Chen, W.; Houldsworth, J.; Olshen, A. B.; Nanjangud, G.; Chaganti, S.; Venkatraman, E. S.; Halaas, J.; Teruya-Feldstein, J.; Zelenetz, A. D.; Chaganti, R. S. K.
Blood (2006)

Fulltext@MSK | Save

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

Journal Article

O'Connor, O. A.; Wright, J.; Moskowitz, C.; Muzzy, J.; Macgregor-Cortelli, B.; Stubblefield, M.; Straus, D.; Portlock, C.; Hamlin, P.; Choi, E.; more...
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma

Meeting Abstract

Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
Blood (2005)

Fulltext@MSK | Save